The new members of the Advisory Committee on Immunization Practices began their tenure Wednesday by shifting the posture of ...

President Donald Trump’s One Big Beautiful Bill Act, sprawling legislation to extend his tax cuts and enact much of his ...

PatientPoint’s Project Futurama featured discussions on staying relevant in a digital age dominated by virtual healthcare and ...

The long-term health care industry is facing a double whammy from President Donald Trump’s crackdown on immigrants and the ...

Nearly seven months after the fatal shooting of an insurance CEO in New York drew widespread attention to health insurers’ ...

Yet despite the increased efforts from various health brands to raise awareness around menopause, both HCPs and patients ...

Millions of Americans who have waited decades for fast internet connections will keep waiting after the Trump administration ...

In Cannes last week, creative leaders from Area 23, The Bloc, Eversana and MMC joined MM+M in the Palais basement to walk the ...

Historic changes are afoot for pharma as China gains ground on U.S. production. The pharma industry is projected to see ...

Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.

Whether it’s building trust or ecosystems, the key to effective consumer engagement is being open. This point was driven home ...

The accolade marks the fifth consecutive year win for Healthcare Network of the Year for an IPG agency. In addition to FCB ...